Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Peripheral Vascular Stents Market, by Mode of Delivery
1.4.2 North America Peripheral Vascular Stents Market, by End-use
1.4.3 North America Peripheral Vascular Stents Market, by Product
1.4.4 North America Peripheral Vascular Stents Market, by Stents Type
1.4.5 North America Peripheral Vascular Stents Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter’s Five Forces Analysis
Chapter 4. Strategies developed in Peripheral Vascular Stents Market
Chapter 5. North America Peripheral Vascular Stents Market by Mode of Delivery
5.1 North America Balloon-expandable Stents Market by Region
5.2 North America Self-expanding Stents Market by Region
Chapter 6. North America Peripheral Vascular Stents Market by End-use
6.1 North America Hospitals & Cardiac Centers Market by Country
6.2 North America Ambulatory Surgical Centers Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Peripheral Vascular Stents Market by Product
7.1 North America Iliac Artery Stents Market by Country
7.2 North America Femoral Artery Stents Market by Country
7.3 North America Carotid Artery Stents Market by Country
7.4 North America Renal Artery Stents Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Peripheral Vascular Stents Market by Stents Type
8.1 North America Drug Eluting Stents (DES) Market by Country
8.2 North America Bare Metal Stents (BMS) Market by Country
8.3 North America Bioabsorbable Stents Market by Country
Chapter 9. North America Peripheral Vascular Stents Market by Country
9.1 US Peripheral Vascular Stents Market
9.1.1 US Peripheral Vascular Stents Market by Mode of Delivery
9.1.2 US Peripheral Vascular Stents Market by End-use
9.1.3 US Peripheral Vascular Stents Market by Product
9.1.4 US Peripheral Vascular Stents Market by Stents Type
9.2 Canada Peripheral Vascular Stents Market
9.2.1 Canada Peripheral Vascular Stents Market by Mode of Delivery
9.2.2 Canada Peripheral Vascular Stents Market by End-use
9.2.3 Canada Peripheral Vascular Stents Market by Product
9.2.4 Canada Peripheral Vascular Stents Market by Stents Type
9.3 Mexico Peripheral Vascular Stents Market
9.3.1 Mexico Peripheral Vascular Stents Market by Mode of Delivery
9.3.2 Mexico Peripheral Vascular Stents Market by End-use
9.3.3 Mexico Peripheral Vascular Stents Market by Product
9.3.4 Mexico Peripheral Vascular Stents Market by Stents Type
9.4 Rest of North America Peripheral Vascular Stents Market
9.4.1 Rest of North America Peripheral Vascular Stents Market by Mode of Delivery
9.4.2 Rest of North America Peripheral Vascular Stents Market by End-use
9.4.3 Rest of North America Peripheral Vascular Stents Market by Product
9.4.4 Rest of North America Peripheral Vascular Stents Market by Stents Type
Chapter 10. Company Profiles
10.1 Boston Scientific Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Medtronic PLC
10.2.1 Company overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent strategies and developments:
10.2.5.1 Acquisition and Mergers:
10.2.6 SWOT Analysis
10.3 Terumo Corporation
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expenses
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Product Launches and Product Expansions:
10.3.5.3 Acquisition and Mergers:
10.3.6 SWOT Analysis
10.4 Abbott Laboratories
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Acquisition and Mergers:
10.4.6 SWOT Analysis
10.5 Biotronik SE & Co. KG
10.5.1 Company Overview
10.5.2 SWOT Analysis
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Acquisition and Mergers:
10.6.6 SWOT Analysis
10.7 Cook Medical, Inc. (Cook Group)
10.7.1 Company Overview
10.7.2 SWOT Analysis
10.8 MicroPort Scientific Corporation
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.8.5 SWOT Analysis
10.9 LifeTech Scientific Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 SWOT Analysis
10.10. iVascular S.L.U.
10.10.1 Company Overview
10.10.2 Recent strategies and developments:
10.10.2.1 Product Launches and Product Expansions:
10.10.3 SWOT Analysis
Unique Offerings 